The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report
Weidman, M.K., R. Sharma, S. Raychaudhuri, P. Kundu, W. Tsai, and A. Dasgupta. 2003. The interaction of cytoplasmic RNA viruses with the nucleus. Virus Research 95(1-2):75-85.
Wenner, H.A., A. Kamitsuka, M. Lenahan, and I. Archetti. 1959. The pathogenesis of poliomyelitis, site of multiplication of poliovirus in cynomolgus monkeys after alimentary infection. Archiv fur die Gesamte Virusforschung 9:537-558.
WHO (World Health Organization). Polio Weekly Global Update, December 21, 2005. WHO, Geneva.
Wimmer, E., C.U.T. Hellen, and X. Cao. 1993. Genetics of poliovirus. Annual Review of Genetics 273:353-436.
Wu, J.Z., N. Yao, M. Walker, and Z. Hong. 2005. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase. Mini Reviews in Medicinal Chemistry 5(12):1103-1112.
Yang, Y., R. Rijnbrand, S. Watowich, and S.M. Lemon. 2004. Genetic evidence for an interaction between a picornaviral cis-acting RNA replication element and 3CD protein. Journal of Biological Chemistry 279(13):12659-12667.
Yeung, M.L., Y. Bennasser, S.Y. Le, and K.T. Jeang. 2005. siRNA, miRNA and HIV: promises and challenges. Cell Research 15(11-12):935-946.
Ypma-Wong, M.F., P.G. Dewalt, V.H. Johnson, J.G. Lamb, and B.L. Semler. 1988. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 166:265-270.